Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_assertion type Assertion NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_head.
- NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_assertion description "[We found that BCAR3 was highly expressed in multiple breast cancer cell lines, where it associated with another protein, p130(Cas) (also known as breast cancer antiestrogen resistance-1; BCAR1), that plays a role in both tamoxifen resistance and cell motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_provenance.
- NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_assertion evidence source_evidence_literature NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_provenance.
- NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_assertion SIO_000772 17616674 NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_provenance.
- NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_assertion wasDerivedFrom befree-20140225 NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_provenance.
- NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_assertion wasGeneratedBy ECO_0000203 NP601953.RArp0Rajb1L8Nn20_3V_DjL-bdF8mdi7W2d5Dc0-x_lcw130_provenance.